Fairfax, Va., January 26, 2010 - The Radiation Oncology Institute has so far raised $8.6 million towards its initial campaign goal of $10 million. This includes a recent pledge of $50,000 from Radiation Business Solutions (RBS) and RBS President Dan Moore, a full-service financial company exclusive to the field of radiation oncology that provides site audits, credentialing, payer contract negotiation, HL7 compatibility, software and billing services to radiation oncology practices nationwide.
“Radiation Business Solutions is grateful for the opportunity to contribute to ROI. As a smaller company, our contribution is a significant portion of our net income. Such a sizable donation may not be the most prudent business decision, but is something that we can put the heart of our company behind,” he said. “There are so many encroaching groups and physicians interested in the financial aspect of radiation oncology and decisions are based on reimbursement, not patient needs or efficacy of treatment. The 10-year horizon could look very different for radiation oncology, and we saw ROI as a way to help direct that future. I am glad to report that our clients have joined us in support of ROI and I hope to continue to raise the awareness for ROI.” Moore said RBS sees investing in ROI as an opportunity to invest in the future of the radiation oncology industry.
With the future in mind, the newly elected ROI Board of Trustees is focusing on the development of a national research needs agenda. “The ROI is thankful to receive this very generous donation from RBS and Dan Moore,” ROI President Theodore Lawrence, M.D., Ph.D., FASTRO, said. “ROI’s mission is critical to the future of the specialty and all the cancer patients whose lives are saved by radiation therapy. With support such as this from the radiation oncology community, we will be better able to gather objective data documenting the effectiveness of radiation therapy as well as support education and research in this important form of treatment.”
The Radiation Oncology Institute (ROI) is a non-profit, 501 (c)(3) foundation created in 2006 by the American Society for Radiation Oncology (ASTRO) Board of Directors to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. ROI strategically funds research on new and existing radiation therapy treatments to identify links between best practices and improved outcomes, to evaluate the efficacy and cost-benefit of radiation therapy and to foster multi-institutional research in radiation oncology. The ROI recently launched the National Radiation Oncology Registry (NROR) pilot program to collect standardized information about patient care to help inform quality improvement initiatives and provide meaningful benchmarks for the radiation oncology field.